The investigation into the cutaneous silent period in patients with essential tremor pre-treatment and post-treatment

被引:4
|
作者
Sonkaya, Ali Riza [1 ]
Senol, Mehmet Guney [2 ]
Demir, Serkan [2 ]
Ozdag, Fatih Mehmet [2 ]
机构
[1] Erzurum Maresal Cakmak Mil Hosp, Dept Neurol, Erzurum, Turkey
[2] GATA Haydarpasa Training Hosp, Dept Neurol, Istanbul, Turkey
关键词
Essential tremor; Propranolol; Cutaneous silent period;
D O I
10.1007/s13760-015-0580-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although essential tremor (ET) is the most common movement disorder, little is known regarding its pathophysiology. Cutaneous silent period (CSP) is a spinal inhibitory reflex that causes suppression of the voluntary muscle contraction that is induced by strong electrical stimulation of the cutaneous nerves. Clinical interest in the CSP stems from its potential usefulness for evaluating segment and components of sensory nerves that are not well assessed by standard electrodiagnostic methods. The aim of this study was to investigate CSP in patients with ET before and after treatment. A total of 30 patients (12 females + 18 males), having ET diagnosis and propranolol treatment initiated, were studied with technique of CSP. Patient group's pre-treatment latency average is found 84.45 +/- 18.63, average CSP duration 42.37 +/- 11.82, and CSP final latency average 127.10 +/- 19.13. According to post-treatment CSP analysis, it is seen that patients' average latency values are found 83.14 +/- 20.92 and it is determined that there is no significant statistical difference compared to pre-treatment latency values (p > 0.05). Post-treatment average CSP duration is found 36.64 +/- 13.38, and it is seen that there is a significant statistical shortening compared to pre-treatment durations (p < 0.05). Patients' post-treatment CSP final latency averages are found 123.17 +/- 13.67, and it is determined that there is no significant statistical difference compared to pre-treatment latency values (p > 0.05). The main finding of this study is that in ET the CSP is prolonged and that treatment with propranolol shortens the CSP and brings it closer to normal values. A small dose of propranolol has the effect of shortening pathologically prolonged CSP in a subset of ET patients (women and without family history), making further investigations with this method interesting. From this point of view in our study, patients with ET treatment give an idea of the effectiveness of propranolol. In recent years, a technique of CSP is interested in the field of electrophysiology and shows the effect of ET that given other pharmacological treatment and also it can be considered a quantitative measure to compare them. The usefulness of CSP should be supported by further studies with more patients.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 50 条
  • [1] The investigation into the cutaneous silent period in patients with essential tremor pre-treatment and post-treatment
    Ali Riza Sonkaya
    Mehmet Güney Şenol
    Serkan Demir
    Fatih Mehmet Özdağ
    Acta Neurologica Belgica, 2016, 116 : 583 - 588
  • [2] The cutaneous silent period in essential tremor
    Ipekdal, I. H.
    Karadas, O.
    JOURNAL OF NEUROLOGY, 2014, 261 : S323 - S324
  • [3] The cutaneous silent period in essential tremor
    Ipekdal, I. H.
    Karadas, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 488 - 488
  • [4] THE CUTANEOUS SILENT PERIOD DURATION CHANGES IN ESSENTIAL TREMOR PATIENTS
    Akgun, Hakan
    Tasdemir, Serdar
    Alay, Semih
    Oz, Oguzhan
    Ulas, Umit Hidir
    Demirkaya, Seref
    MUSCLE & NERVE, 2014, 50 (04) : 637 - 637
  • [5] NUTRITIONAL STATUS OF CANCER ESOPHAGUS IN PRE-TREATMENT AND POST-TREATMENT PERIOD AND CORRELATION WITH TREATMENT OUTCOME
    GhoshDastidar, A.
    Basu, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 43 - 44
  • [6] Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies
    Cady, R.
    Martin, V.
    Mauskop, A.
    Rodgers, A.
    Hustad, C. M.
    Ramsey, K. E.
    Skobieranda, F.
    CEPHALALGIA, 2007, 27 (09) : 1055 - 1060
  • [7] Pre-treatment and post-treatment changes in platelet indices in patients with immune thrombocytopenia
    Korkmaz, Serdal
    Uslu, Ali U.
    Aydin, Bahattin
    Dogan, Ozgur
    Sencan, Mehmet
    SAUDI MEDICAL JOURNAL, 2013, 34 (06) : 591 - 596
  • [8] Pre-Treatment and Post-Treatment Demodex Densities in Patients under Immunosuppressive Treatments
    Keles, Hacer
    Yuksel, Esra Pancar
    Aydin, Fatma
    Senturk, Nilgun
    MEDICINA-LITHUANIA, 2020, 56 (03):
  • [10] Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients
    Tsiropoulos, G.
    Papadas, T.
    Triantaphyllidou, I. E.
    Naxakis, S.
    Markou, K.
    Triaridis, S.
    Vital, I
    Goumas, P.
    Vynios, D. H.
    HIPPOKRATIA, 2013, 17 (03) : 220 - 227